Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer

Cancer Control : Journal of the Moffitt Cancer Center
Jade Homsi, Christopher R Garrett

Abstract

Sixty percent of colon cancer patients develop liver metastasis. Only 25% of those have potentially resectable hepatic metastases, and approximately 58% of those patients relapse. We review the indications and the technical aspects of hepatic artery infusion (HAI) of chemotherapy, as well as the efficacy, morbidity, and outcomes. HAI of chemotherapy has been used following hepatic metastasectomy, in patients with unresectable metastases, or in combination with other agents. Floxuridine, the chemotherapeutic agent most studied, is administered through an implantable subcutaneous infusion pump connected to a surgically placed hepatic artery catheter, which delivers the chemotherapeutic agents at a slow fixed rate. Treatment-related toxicities include chemical hepatitis, biliary sclerosis, and peptic ulceration. Some trials report a survival benefit for HAI over systemic chemotherapy with acceptable toxicity. Regional perfusion chemotherapy can be logistically and technically complicated to deliver. The development of newer systemic agents with superior efficacy in the treatment of metastatic colorectal cancer will likely diminish the role of regional perfusion therapy in the future.

References

Jul 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P RougierD Gallot
Nov 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L D WagmanD U Riihimaki
Nov 1, 1990·The British Journal of Surgery·J ScheeleA Altendorf-Hofmann
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N KemenyJ R Bertino
May 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K A CampbellJ E Niederhuber
Mar 6, 1996·Journal of the National Cancer Institute·UNKNOWN Meta-Analysis Group in CancerE Levy
May 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N KemenyP Paty
Apr 16, 2002·Seminars in Oncology·Don S Dizon, Nancy E Kemeny
Feb 8, 2003·Lancet·David J KerrUNKNOWN European Organisation for Research and Treatment of Cancer colorectal cancer study group
Feb 13, 1964·The New England Journal of Medicine·R D SULLIVANE WATKINS
Sep 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L ZelekUNKNOWN European Association for Research in Oncology, Créteil, France
Dec 6, 2003·The Oncologist·Adam D Cohen, Nancy E Kemeny
Jan 22, 2005·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 28, 2005·Cancer Control : Journal of the Moffitt Cancer Center·Todd Alekshun, Chris Garrett
Jul 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy KemenyYuman Fong
Jul 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michel DucreuxUNKNOWN gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer
Jul 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Moshe FaynsodLucille A Leong

❮ Previous
Next ❯

Citations

Dec 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Simone MocellinDonato Nitti
Jun 20, 2017·Organic & Biomolecular Chemistry·Chao LiuPiet Herdewijn
Dec 27, 2011·Chemistry and Physics of Lipids·Muneeb AhmedS Nahum Goldberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.